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Background: With the use of broad-spectrum antibiotics, immunosuppressive drugs, and glucocorticoids,
multidrug-resistant Acinetobacter baumannii (MDR-AB) has become a major nosocomial pathogen species. The
recent renaissance of bacteriophage therapy may provide new treatment strategies for combatting drug-resistant
bacterial infections. In this study, we isolated a lytic bacteriophage vB_AbaM-IME-AB2 has a short latent period and
a small burst size, which clear its host’s suspension quickly, was selected for characterization and a complete
genomic comparative study.
Results: The isolated bacteriophage vB_AbaM-IME-AB2 has an icosahedral head and displays morphology
resembling Myoviridae family. Gel separation assays showed that the phage particle contains at least nine protein
bands with molecular weights ranging 15–100 kDa. vB_AbaM-IME-AB2 could adsorb its host cells in 9 min with an
adsorption rate more than 99% and showed a short latent period (20 min) and a small burst size (62 pfu/cell). It
could form clear plaques in the double-layer assay and clear its host’s suspension in just 4 hours. Whole genome of
vB_AbaM-IME-AB2 was sequenced and annotated and the results showed that its genome is a double-stranded
DNA molecule consisting of 43,665 nucleotides. The genome has a G + C content of 37.5% and 82 putative coding
sequences (CDSs). We compared the characteristics and complete genome sequence of all known Acinetobacter
baumannii bacteriophages. There are only three that have been sequenced Acinetobacter baumannii phages AB1,
AP22, and phiAC-1, which have a relatively high similarity and own a coverage of 65%, 50%, 8% respectively when
compared with our phage vB_AbaM-IME-AB2. A nucleotide alignment of the four Acinetobacter baumannii phages
showed that some CDSs are similar, with no significant rearrangements observed. Yet some sections of these strains
of phage are nonhomologous.
Conclusion: vB_AbaM-IME-AB2 was a novel and unique A. baumannii bacteriophage. These findings suggest a
common ancestry and microbial diversity and evolution. A clear understanding of its characteristics and genes is
conducive to the treatment of multidrug-resistant A. baumannii in the future.
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Acinetobacter baumanni is a non-fermentative, aerobic,
gram-negative bacillus, and is an opportunistic pathogen
with global distribution. It is frequently found in elderly
patients and cancer patients with compromised immune
function, especially in intensive care units. With the use of
broad-spectrum antibiotics, immunosuppressive drugs, and
glucocorticoids, A. baumannii (AB) has become a major
nosocomial pathogen species [1]. Multidrug-resistant
(MDR), extensively drug-resistant (XDR), and pan drug-
resistant (PDR) A. baumannii strains are increasingly
prevalent [2]. MDR-AB refers to A. baumannii strains that
are resistant to at least three of the following five types
of antimicrobial agents: cephalosporins, carbapenems,
β-lactamase inhibitors (including piperacillin/tazobactam,
cefoperazone/sulbactam, ampicillin/sulbactam), fluoroqui-
nolones, and aminoglycosides [2-4].
Bacteriophage therapy is a potential alternative treat-
ment for multidrug-resistant bacterial infections [5]. A
bacteriophage is a bacterial virus that can lyse and kill
the host cell. Phage-related studies have gone through
three stages. Félix d’Herelle discovered bacteriophage for
the treatment of bacterial infections in 1917 [6]. After the
emergence of antibiotics in the 1940s, phages were seldom
used for therapeutic purposes, and mainly functioned as
molecular and genetic research tools. With the recent
emergence of multidrug-resistant bacteria, however, there
has been renewed interest in methods of phage therapy
[7]. In this study we isolated a lytic bacteriophage IME-
AB2, and compared biological characteristics and genomic
sequence with other Acinetobacter baumannii phages. The
genomes of A. baumannii phages IME-AB2, A. baumannii
AB1, A. baumannii AP22, and A. baumannii phiAC-1
were compared thoroughly in this study. To our know-
ledge this is the first report of comparison of the character-
istics and complete genome sequence of Acinetobacter
baumannii bacteriophages. A clear understanding of its
genes is conducive to the treatment of multidrug-resistant
A. baumannii in the future.
Results
Isolation of a lytic bacteriophage against multidrug-resistant
A. baumannii
A. baumannii strain MDR-AB2, isolated from a sputum
sample of a patient with pneumonia at PLA Hospital 307,
was resistant to multiple antibiotics (Table 1). The bacteria
was used to screen bacteriophages in sewage samples from
PLA Hospital 307. The isolated phage was designated as
vB_AbaM-IME-AB2 following the recommendation by
International Committee on Taxonomy of Viruses in
phage nomenclature [8]. The pahge IME-AB2 could
form clear plaques in the double-layer assay and clear
its host’s suspension in just 4 hours (Figure 1), indicating
that it is a lytic phage. In order to check the developmentof resistance, we had extended the period of the experi-
ment to 24 h. The result indicated that the bacterial sus-
pension became turbid finally. The final suspension was
plated on solid LB culture and then some single bacterial
clones were picked to be used for 16 s rDNA sequencing.
The sequences of 16 s rDNA proved that the final sus-
pension was A. baumannii that developed resistance to
IME-AB2. The phage particles were concentrated with
PEG6000 and then purified with a cesium chloride gra-
dients density to a titer of 1 × 1011 pfu/ml. Observation
under an electron microscope showed that the phage
IME-AB2 consisted of an icosahedral head and a con-
tractile tail. The total length of the phage from the top
of the head to the bottom of the tail was about 160 nm,
with the head measuring approximately 61.2 nm, and
the tail about 90 nm. This morphology suggested that
phage IME-AB2 should be classified as a member of the
Myoviridae family (Figure. 2). Among the 22 clinical strains
of A. baumannii, only three strains of A. baumannii
(MDR-AB1139, MDR-AB2 and MDR-AB11) could be
lysed by the phage IME-AB2.
Growth and lytic characteristics of IME-AB2
To determine the optimal multiplicity of infection
(MOI) of IME-AB2, the phage and its host cells were
mixed at various ratios, and incubated for 3.5 h at 37°C.
The results indicated that a MOI of 20 gave the highest
production of phage progeny (3.5 × 1011 pfu/ml). To
examine the host adsorption ability of phage IME-AB2,
host bacteria were infected with IME-AB2 at a MOI of
0.1 and incubated at 37°C. Aliquots were taken at 0, 3,
6, 9, 12, 15, and 18 min post-infection and assayed for
the absorbed phage by titration using the double-layer
method. The percentages of phage absorption at differ-
ent time points were plotted (Figure 3a). The results
showed that phage IME-AB2 had an adsorption rate of
50% within 3 min, 80% within 6 min and 99% within
9 min.
For one-step growth curve analysis, MDR-AB2 cells
(OD600 = 0.3) were infected with phage IME-AB2 at a
MOI of 0.1. The bacteriophage was allowed to adsorb
for 15 min at 37°C [9]. The mixture was then centri-
fuged at 12,000 × g for 30 s to remove unadsorbed phage
particles, and the resultant pellet was re-suspended in
5 ml of LB medium. Samples were incubated at 37°C
and collected every 10 min during 0–60 min, as well as
at 90 and 120 min [10]. As shown in Figure 3b, the latent
period of phage IME-AB2 lasted for 20 min, the burst
period reached a peak at 30 min, and the phage multipli-
cation reached the final plateau phase at 50 min. The
burst size of phage IME-AB2 was determined to be 62
pfu/cell (burst size = the total number of phages liberated
at the end of one cycle of growth /the number of infected
bacteria) [11].
Table 1 Antibiotic resistance profile of A. baumannii strain MDR-AB2
Antibiotics MIC (μg/ml) Sensitivity Antibiotics MIC (μg/ml) Sensitivity
Ampicillin ≥ 32 Resistant nitrofurantoin ≥ 512 Resistant
Ciprofloxacin ≥ 4 Resistant ampicillin/sulbactam ≥ 32 Resistant
Gentamicin ≥ 16 Resistant aztreonam ≥ 64 Resistant
Imipenem ≥ 16 Resistant cefepime ≥ 64 Resistant
Meropenem ≥ 16 Resistant cefotetan ≥ 64 Resistant
Piperacillin ≥ 128 Resistant ceftazidime ≥ 64 Resistant
Piperacillin/tazobactam ≥ 128 Resistant ceftriaxone ≥ 64 Resistant
Tobramycin ≥ 16 Resistant cefuroxime axetil ≥ 64 Resistant
Cotrimoxazole ≥ 320 Resistant cefuroxime sodium ≥ 64 Resistant
Levofloxacin ≥ 8 Resistant cefoperazone/sulbactam ≥ 64 Resistant
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Purified phage particles were denatured in loading buf-
fer (50 mM Tris–HCl, 2% Sodium Dodecyl Sulfate-
polyacrylamide, 0.1%Bromophenol blue, 10% Glycerol and
1% β-Mercaptoethanol) and heated in a boiling water bathFigure 1 The MDR-AB2 suspension at the different optical density (O
respectively after added 200ul IME-AB2 (1 × 1011 pfu/ml) to the 10 m
The control shows increasing OD600nm. The MDR-AB2 suspension addedfor 5 min, followed by separation of the proteins by so-
dium dodecyl sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE). The results indicated that the structural
proteins of phage IME-AB2 showed a pattern of nine
protein bands in 10% SDS-PAGE gel, with molecularD600nm) reached to 0.4 from 1.6 and reached to 0.08 from 0.6
l MDR-AB2 suspension. It clear its host’s suspension in just 4 hours.
with IME-AB2 finally became turbid in 24 hours.
Figure 2 Transmission electron microscopy of phage IME-AB2.
The bidirectional arrows indicated the length of intact phage, phage
tail and head. The bar represents a length of 200 nm.
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abundant protein band in the gel above 35 kDa was ana-
lyzed with liquid sampling Mass Spectrometry (LS-MS)
and proved to be the phage putative capsid protein.
The genome analysis indicated that phage IME-AB2 has
a double-stranded DNA genome, approximately 40 kb in
size. The genome of phage IME-AB2 could be digested
with endonuclease NdeI, HincII and HindIII (Figure 4b). It
was found that endonuclease enzymes, HindIII and HincII,
have the 35 and 16 cutting sites on the genome of phage
IME-AB2 respectively by Vector NTI [12]. Compared to
other A. baumannii complete genome , the two endonu-
cleases also have most restriction enzyme cutting sites on
them.
High-throughput sequencing of the phage genomic
DNA generated 311,503 valid reads with which the
complete sequence of the genome was assembled using
both Velvet and CLC Genomic Workbench, with an
average coverage of 785 × [13]. The complete genome of
phage IME-AB2 consists of 43,665 bp, with an average
GC content of 37.5% (Figure 5). Annotation results showed
that the genome encodes 82 coding sequences (CDSs)(GenBank Assession number: JX976549). The classification
of the 82 CDSs is shown in Table 2 and Figure 6. The
complete genome of IME-AB2 is organized into three
functional units which encoding structural proteins, meta-
bolic proteins and packaging-associated proteins respect-
ively. No tRNA was found in the genome of IME-AB2,
and no significant proteins considered to be markers of
temperate bacteriophages were identified. Running blastn
showed that the isolated IME-AB2 has a high similarity to
Acinetobacter phage AB1 (Genbank Accession Number:
HM368260.1), Acinetobacter phage AP22 (Genbank
Accession Number: HE806280.1) and Acinetobacter phage
phiAC-1 (GenBank accession number: JX560521), which
were isolated in China, Russia and Korea respectively. The
phage AB1, AP22 or phiAC-1 has a genome of about
45 kb and owns a coverage of 65%, 50%, 8% respectively
when compared with the isolated phage IME-AB2. Gen-
omic annotation found that IME-AB2 encodes 82 CDSs,
AB1 85 CDSs, AP22 89 CDSs, phiAC-1 82 CDSs. The 82
CDSs from IME-AB2 shared 63 homologues with AB1, 60
homologues with AP22 and 36 homologues with phiAC-1
respectively (Table 3). Totally, 22 of the 82 CDSs encoded
by IME-AB2 were identified to be putatively functional.
Genomic analysis revealed that the bacteriophage IME-
AB2 was most closely related to AB1. A nucleotide align-
ment of the four Acinetobacter baumannii phages showed
that some functional regions are highly homologous,
with no significant rearrangements observed (Table 3
and Figure 7). It revealed a stable area. Stability is suggested
from the high level of nucleotide identity, lack of inversions
and other major rearrangements, and the stabilizing selec-
tion inferred for virtually all genes harboring synonymous
and non-synonymous mutations [14]. Functional related
genes are sequential, yet there are a lot of breakpoint mod-
ules obviously and some sections of these strains of phages
are nonhomologous (Table 3 and Figure 7). It illustrated
that these structural genes had occurred in the extensive
structural rearrangements during evolution. Bacteriophages
are the most diverse and abundant biological entities in na-
ture environment. Most of them can hardly to be found
homologous to another bacteriophage, which means evolu-
tionary success obtained by bacteriophages. Furthermore,
the diversity is such that even genes with required functions
cannot always be recognized. During bacteriophage evolu-
tion,the elimination or recombination of genes result in
the diversity and meanwhile confer a selective advantage
to survive and infect so that phages can better adapt to
host bacteria.
Structural proteins
Seven CDSs encoding structural proteins were identified
in the phage IME-AB2. The putative capsid protein
(CDS.12) is similar to that of phage AB1 (gp15), phage
AP22 (gp30), phage phiAC-1 (0043). Phage AB1 (gp27),
Figure 3 Biological characteristics of phage IME-AB2. a. Host adsorption ability of phage IME-AB2. b. One-step growth curve of
phage IME-AB2.
Peng et al. BMC Microbiology 2014, 14:181 Page 5 of 14
http://www.biomedcentral.com/1471-2180/14/181phage AP22 (gp18), phage phiAC-1 (0031) also share
homology to the putative phage head protein encoded
by IME-AB2 CDS.24. CDS.71 and CDS.72 of phage IME-
AB2 are identified to be associated with tail fiber protein.
CDS.74 and CDS.77 of phage IME-AB2 are predicted to
encode proteins responsible for baseplate. These two re-
lated proteins can be found similar area in the other three
phages. The results also demonstrate the phage tail related
proteins generally cluster together (Table 3).
Metabolic proteins
A unique feature of the IME-AB2 genome is that it en-
codes cobalt transport protein (CDS.6). Notably, cobalt
is a cofactor and is required by enzymes from bacteria
[15]. It is possible that these metabolic enzymes benefit
phage by enhancing the metabolism of the infected
bacterial cell, which could in turn increase phage pro-
liferation. No similar cobalt proteins were found in the
other three phages sharing homology with IME-AB2.
CDS.8 encodes a putative RNA polymerase protein. It
is necessary for constructing RNA chains using DNA genes
as templates, a process called transcription. Transcriptionof most double-stranded DNA bacteriophages rely on
their host bacteria [16]. The putative CDS.33 of IME-
AB2 is predicted to encode HTH domains which have
been recruited to a wide range of functions beyond
transcription regulation, such as DNA repairing and
replication, RNA metabolism and protein-protein in-
teractions in diverse signaling contexts. Beyond their
basic role in mediating macromolecular interactions,
the HTH domains have also been incorporated into the
catalytic domains of diverse enzymes [17]. In func-
tional terms, the HNH endonuclease domain (CDS.52)
is found in CRISPR-related proteins. CRISPR functions
as a prokaryotic immune system, in that it confers
resistance to exogenous genetic elements [18]. CDS.47
is predicted to be a putative bacteriophage-associated
immunity protein, which was considered to be responsible
for phage superinfection immunity [19]. CDS.68 and
CDS.81 are putative lysozyme family protein. Unlike,
CDS.0057, 0058, 0059 encoded by phiAC-1, which are
putative lysozyme-like domain protein and adjacent to
each other, the two lysozyme-like proteins from IME-AB2
are not clustered.
Figure 4 Protein and genomic DNA analysis of phage IME-AB2. a. SDS-PAGE gel (10%) of whole protein from phage IME-AB2. Molecular
weights of protein marker was indicated by lines. b. Endonuclease digestion analysis of phage IME-AB2 genomic DNA. Phage IME-AB2 genomic DNA
was digested with the restriction enzyme NdeI, HincII and HindIII. The digested DNA fragments were separated by 1% agarose gel electrophoresis. M,
DNA molecular weight marker; Lanes 1, undigested phage IME-AB2 genomic DNA; lane 2, 3, 4, genomic DNA digested with NdeI , HincII and
HindIII, respectively.
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In the four similar Acinetobacter baumannii phages, the
genetic elements encoding the products involved in the
packaging system are commonly found adjacent to one
another in the phage genomes. Packaging system is gener-
ally composed of big subunit (CDS.27) and small subunit
(CDS.28). Usually, the two subunits of the terminase and
head portal protein (CDS.26) are closely connected in the
packaging system, while the portal protein is a bacterio-
phage component that forms a hole, or portal, enabling
DNA passage during packaging and ejection [20]. It also
forms the junction between the phage head (capsid) and
the tail proteins.
Discussion
With the emergence of a growing number of drug-
resistant bacterial species, and the difficulties surrounding
the development of novel antibiotics [21], exploring novel
or alternative therapeutic methods is imperative. The re-
cent renaissance of bacteriophage therapy may provide
new treatment strategies for combatting drug-resistant
bacterial infections. Although a large number of work on
phage therapy in human disease had been done [22-24],the host-specific infection and the relatively narrow lytic
spectrum of phage is one of the obstacles to their further
application. Individualized phage therapy may represent
the future of phage therapy, where bacterial infections will
be treated with phage combinations that have already
been shown as effective for that particular bacterium. To
overcome these limitations, strategies such as screening
more lytic phages, combining phages with antibiotics, or
administrating phages cocktails should be investigated
[25,26]. Therefore, it is very important to isolate novel and
sensitive phages to enrich the phage arsenal [27].
All known Acinetobacter baumannii bacteriophages
were summarized and compared in this research. There
are nearly 20 A. baumannii phage strains reported in the
literature mainly in 2012. Most of the phages genome
length are about 40 kb. Just only thirteen complete A.
baumannii phage genomes were sequenced and deposited
in the GenBank database currently. Five of those genomes
consist of an approximately 160 kb linear DNA molecule
(Acinetobacter phage Ac42,Acj61,Acj9,133,and ZZ1), and
are annotated as T4-like phage [5,28]. The remaining eight
phages contain a genome of 30–50 kb, and may be clas-
sified into two different groups according to sequence
Figure 5 Circular map of the IME-AB2 genome prepared using CGView. The outer ring denotes the IME-AB2 genome and CDSs. The inner
rings show G + C content and G + C skew, where peaks represent the positive (outward) and negative (inward) deviation from the mean G + C
content and G + C skew, respectively.
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linear genome, including phiAB1, which was already
classified as a ϕKMV-like virus [29], phage YMC/09/02/
B1251_ABA_BP [30], Acinetobacter phage AB3 and Aci-
netobacter phage Abp1. The other group includes four
phages: AB1 (GenBank accession number: HM368260),
AP22 (GenBank accession number: HE806280), phiAC-1
(GenBank accession number: JX560521), and our phage
IME-AB2. We compared the growth characteristics and
the genome of A. baumannii phage as shown in Table 4.
The results indicated that the newly isolated phage IME-
AB2 has a shorter latent and burst period than AB1 and
AP22, which implied that the IME-AB2 was more lytic
and the burst size produced by IME-AB2 was smaller than
those phages [31]. All the listed A. baumannii bacterio-
phages or its lysin had been tested in treating bacterial in-
fection such as inhibiting biofilm formation or effectingon host cell survival. Although the bacteriophage IME-
AB2 could lyse the host bacteria and cleared the bacterial
suspension in 4 hours, we observed that the resistant bac-
teria appeared and made the suspension turbid again in
24 hours. The easily emerging resistant bacteria after infec-
tion with phage might be an obstacle when fighting against
bacterial infection with bacteriophage in the future.
Conclusions
A lytic A. baumannii bacteriophage IME-AB2 was isolated
and characterized in this research. The complete genome
of IME-AB2 was sequenced and compared to those of A.
baumannii phage AB1, A. baumannii phage AP22, and A.
baumannii phage phiAC-1 in detail. The genome of IME-
AB2 was replete with novel genes without known relatives,
which indicated that IME-AB2 was a novel and unique
A. baumannii bacteriophage. Although the resistant A.
Table 2 Functional classification of the 82 CDSs in the IME-AB2 genome
Category CDSs and putative functions
Structural proteins CDS.12 putative capsid protein.
CDS.13 putative structural protein.
CDS.24 putative phage head protein.
CDS.71 putative tail fiber.
CDS.72 similar to the N-terminal region of tail fiber protein.
CDS.74 putative baseplate J-like protein.
CDS.77 putative phage baseplate assembly protein.
Metabolic proteins CDS.06 putative cobalt transport protein.
CDS.08 putative RNA polymerase.
CDS.33 putative binding HTH domain or homeodomain-like.
CDS.47 putative bacteriophage-associated immunity protein.
CDS.52 putative HNH endonuclease domain protein.
CDS.66 putative nucleoside triphosphate pyrophosphohydrolase.
CDS.68 putative lysozyme family protein.
CDS.81 putative lysozyme protein.
Replication/packaging-associated proteins CDS.26 putative phage head portal protein.
CDS.27 putative phage terminase, large subunit.
CDS.28 putative phage terminase,small subunit.
CDS.50 putative replicative DNA helicase.
CDS.51 putative primosomal protein.
CDS.58 putative transcriptional regulator.
CDS.62 putative recombinational DNA repair protein.
Other hypothetical proteins CDS.1,2,3,4,5,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,25,26,29,30,31,
32,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,51,53,54,55,56,57,59,60,
61,63,64,65,67,69,70,73,75,76,78,79,80,82.
Figure 6 Genome map of phage IME-AB2. Arrows indicate putative CDSs, along with their orientations. Functionally assigned genes are
differently colored (purple, structural gene; green, metabolic gene; orange, replication/packaging-associated gene; blue, other gene). Promoters
are illustrated as green arrowheads, while terminators are displayed as red arrowheads.
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Table 3 Comparative genomic analysis of A. baumannii phage IME-AB2, A. baumannii phage AB1, A. baumannii phage
AP22, and A3 baumannii phage phiAC-1
IME-AB2 (82CDSs) AB1 (85CDSs) Score (bits) E-value phiAC-1 (82CDSs) Score (bits) E-value AP22 (89CDSs) Score (bits) E-value
CDS.01 gp01 134 9e-35 0055 190 1e-51 gp42 290 1e-81
CDS.02 gp02 192 4e-52 0054 205 3e-56 gp41 130 9e-34
CDS.03 gp03 895 0.0 0053 645 0.0 gp40 813 0.0
CDS.04 gp04 334 5e-95 0052 207 1e-56 gp39 325 4e-92
CDS.05 gp06 345 2e-98 0051 220 1e-60 gp38 329 2e-93
CDS.06
CDS.07 gp08 57 8e-12 0050 45 3e-08 gp36 52 3e-10
CDS.08 gp09 270 7e-76 0049 99 3e-24 gp35 262 3e-73
CDS.09 gp10 150 4e-40 0048 128 2e-33 gp34 150 4e-40
CDS.10 gp12 298 3e-84 0047 221 5e-61 gp32 299 2e-84
CDS.11 gp13 74 1e-16 0046 75 6e-17 gp31 65 4e-14
CDS.12 gp15 207 2e-56 0043 208 1e-56 gp30 250 2e-69
CDS.13 gp16 120 2e-30 0042 124 1e-31 gp29 99 6e-24
CDS.14 gp17 523 e-151 0041 402 e-115 gp28 546 e-158
CDS.15





CDS.21 gp23 55 4e-11 gp22 71 9e-16
CDS.22
CDS.23 0022 40 1e-06 gp21 39 2e-06
CDS.24 gp27 414 e-119 0031 325 6e-92 gp18 404 e-116
CDS.25 gp28 204 4e-56
CDS.26 gp30 831 0.0 0029 658 0.0 gp17 804 0.0
CDS.27 gp31 627 0.0 0028 64 7e-13 gp16 60 8e-12
CDS.28 gp33 305 2e-86 0027 22 0.82 gp15 20 2.7
CDS.29 gp34 31 6e-04 0038 35 3e-05 gp27 32 3e-04
CDS.30 gp34 35 2e-05 gp14 30 6e-04
CDS.31 gp34 31 6e-04
CDS.32 gp35 149 1e-39 gp12 83 1e-19
CDS.33 gp36 112 1e-28 gp10 114 4e-29
CDS.34
CDS.35 gp39 133 6e-35 gp05 137 4e-36
CDS.36
CDS.37
CDS.38 gp40 147 3e-39 0010 50 1e-09 gp02 124 3e-32
CDS.39 gp42 186 1e-50 0021 152 1e-40
CDS.40 gp88 139 8e-37
CDS.41 gp43 92 3e-22
CDS.42 gp44 152 5e-40 gp87 71 1e-15
CDS.43 gp45 97 7e-24 gp86 95 2e-23
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Table 3 Comparative genomic analysis of A. baumannii phage IME-AB2, A. baumannii phage AB1, A. baumannii phage
AP22, and A3 baumannii phage phiAC-1 (Continued)
CDS.44 gp46 379 e-108 gp85 390 e-112
CDS.45 gp47 388 e-111 gp84 186 6e-50
CDS.46 gp48 68 5e-15 gp83 70 9e-16
CDS.47 gp49 72 2e-16 0019 42 2e-07 gp82 71 4e-16
CDS.48 gp50 192 1e-52
CDS.49 gp51 126 8e-33 0009 42 2e-07 gp79 159 9e-43
CDS.50 gp52 863 0.0 gp77 619 e-180
CDS.51 gp53 204 2e-55 gp76 157 2e-41
CDS.52
CDS.53 gp54 130 5e-34 gp75 133 7e-35
CDS.54
CDS.55 gp57 150 5e-40 gp72 128 3e-33
CDS.56
CDS.57 gp60 72 3e-16 gp69 74 8e-17
CDS.58 gp62 216 6e-59 gp68 295 4e-83
CDS.59 gp63 153 6e-41
CDS.60 gp64 187 9e-51 gp66 192 2e-52
CDS.61 gp65 123 8e-32
CDS.62 gp66 594 e-173
CDS.63 gp67 489 e-141 gp63 38 2e-05
CDS.64 gp68 189 2e-51 gp62 187 5e-51
CDS.65 gp70 59 2e-12 gp61 60 8e-13
CDS.66 gp71 125 5e-32
CDS.67 gp72 143 5e-38 0079 80 1e-18 gp59 128 2e-33
CDS.68
CDS.69 gp74 171 3.00E-46 gp56 174 4e-47
CDS.70 gp75 175 2e-47 gp55 174 3e-47
CDS.71 gp76 221 4e-60 0069 189 1e-50 gp54 252 1e-69
CDS.72 gp77 304 1e-85 0068 216 3e-59 gp53 313 2e-88
CDS.73 gp78 418 e-120 0067 332 3e-94 gp52 421 e-121
CDS.74 gp79 790 0.0 0066 585 e-170 gp51 796 0.0
CDS.75 gp80 213 1e-58 0065 164 4e-44 gp50 214 6e-59
CDS.76 gp49 59 2e-12
CDS.77 gp81 429 e-123 0064 200 2e-54 gp48 430 e-123
CDS.78 gp82 575 e-167 0063 437 e-125 gp47 573 e-166
CDS.79 0061 124 4e-32 gp46 170 5e-46
CDS.80 gp83 352 e-100 0060 277 1e-77 gp45 351 e-100
CDS.81 gp84 710 0.0 0057 368 e-104 gp44 715 0.0
CDS.82 gp85 77 6e-18 0056 61 6e-13 gp43 145 2e-38
IME-AB2 is the reference for alignments and comparisons to the three other strains (AB1,phiAC-1 and AP22).
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AB2, the comprehensive understanding of the phage’s
characteristics is conducive to the treatment of multidrug-
resistant A. baumannii in the future.Methods
Bacterial strains, Phage isolation, propagation, and titration
This study included 22 clinical strains of A. bauman-
nii (MDR-AB1139, MDR-AB1, MDR-AB2, MDR-AB3,
Figure 7 Multiple genome alignment performed using Mauve software (http://asap.ahabs.wisc.edu/mauve/) and the chromosomes of
A. baumannii IME-AB2, A. baumannii AB1, A. baumannii AP22, and A. baumannii phiAC-1. IME-AB2 is the reference for alignments and
comparisons to the three other strains. Boxes with identical colors represent local colinear blocks (LCB), indicating homologous DNA regions
shared by two or more chromosomes without sequence rearrangements. LCBs indicated below the horizontal black line represent reverse
complements of the reference LCB.
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MDR-AB21). All the clinical samples were taken as
part of standard patient care at the PLA Hospital
307, Beijing, China. The patients were orally informed
that the specimens would be used for screening bac-
teria and the tests were optional on laboratory sheet.
Blood, sputum and skin swabs were collected from
patients with consent under the Ethics Committee of the
PLA Hospital 307. The protocol of screening bacteria was
approved by the Ethics Committee of the PLA Hospital
307 and Beijing Institute of Microbiology and Epidemi-
ology Ethics Committee.
Multidrug-resistant A. baumannii strain MDR-AB2 was
used as an indicator for bacteriophage screening of raw
sewage samples collected from PLA Hospital 307. Sewage
samples were separated by centrifugation at 12,000 × g for
20 min. Following removal of the solid impurities by
centrifugation, the supernatants were filtered through a
0.45 μm pore-size membrane filter to remove bacterial deb-
ris. Filtrate (4 ml) was added to 2 ml of 3× Luria-Bertani
(LB) broth medium and mixed with 0.1 ml of A. baumannii
overnight culture (OD600 = 0.6) to enrich the phage at 37°C
overnight. Following enrichment, the culture was centri-
fuged at 12,000 × g for 10 min, and then the supernatant
was filtered with a 0.45 μm pore-size membrane filter to
remove the residual bacterial cells. The filtrate (0.1 ml)was mixed with 0.5 ml of A. baumannii in LB culture
(OD600 = 0.6) and 5 ml of molten top soft nutrient agar
(0.75% agar), which was then overlaid onto solidified base
nutrient agar (1.5% agar) [43]. Following incubation for
6 h at 37°C, the clear phage plaques were picked from the
plate. The phage titer was determined using the double-
layered method previously described by Adams [44].
Phage concentration , purification and storage
A single plaque was picked into 5 ml of LB medium
containing MDR-AB2 (OD600 = 0.6) and cultured at 37°C
for 6 h. A 5 ml aliquot of suspension was transferred
into 500 ml of LB medium for culture at 37°C overnight.
Chloroform was then added to the 500 ml of culture to
a final concentration 0.1% before being mixed gently and
allowed to stand at room temperature for about 30 min.
Solid NaCl was added to the culture to a final concen-
tration of 1 M, which was then incubated in an ice water
bath for 1 h. The culture was centrifuged at 11,000 × g
for 10 min to remove cell debris, and polyethylene glycol
6000 (PEG6000) was added to the supernatant to a final
concentration of 10% (w/v) while slowly stirring with a
magnetic stirrer at room temperature. This solution was
transferred to a polypropylene centrifuge tube in an ice
water bath and incubated at least 1 h to precipitate the
phage particles. Following centrifugation (11,000 × g for
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resuspended in 5 ml of SM buffer (50 mM Tris-Cl,
100 mM NaCl, 8 mM MgSO4, pH 7.5) [45]. An equal
volume of chloroform was then added to separate the
phage particles from PEG6000. Following centrifugation
at 3,000 × g for 10 min, the aqueous phase was recovered
and filtered through a 0.22 μm pore-size membrane fil-
ter to remove debris. The concentrated 1.0 ml of phage
suspensions were layered on the top of a cesium chloride
gradient solutions (density of 1.3 g/ml-0.45 g of cesium
chloride in 1.0 ml of water; density of 1.5 g/ml-0.83 g
of cesium chloride in 1.0 ml of water; density of 1.7 g/
ml-1.28 g of cesium chloride in 1.0 ml of water) in
5.0 ml cellulose nitrate centrifuge tube [46]. After cen-
trifugation in a Beckman Coulter Swinging Bucket
Rotor (SW41, Ti) for 40 min at 100,000 × g, the concen-
trated phages at the visible band were collected by
means of a capillary pipette. The purified phage was
stored at 4°C.
Determination of lytic spectrum
The host range was determined by spot test. Briefly,
0.5 ml of bacterial overnight culture was mixed with 5 ml
of molten top soft nutrient agar (0.75% agar) and then
overlaid on the surface of solidified base nutrient agar
(1.5% agar). Once the top layer also solidified, 2 μl of the
phage preparation(1 × 109 pfu/ml) was spotted onto the
plate, which was incubated for 6 h at 37°C.
Electron microscopy
Phage stock solution was directly stained with phos-
photungstic acid (PTA) for 2 min. After being dried at
room temperature, the grid was examined using a Philips
TECNAI-10 transmission electron microscope (TEM)
to observe and record the morphology of the phage
particles [41].
Extraction of phage genomic DNA
Purified phage particles were treated with DNase I
(1 μg/ml) (Takara) and RNase A (1 μg/ml) (Takara) for
30 min, and then the nucleases were inactivated at 80°C
for 15 min. Ethylene diamine tetraacetic acid (EDTA)
(20 mM), proteinase K (50 μg/ml) and sodium dodecyl
sulfate (SDS) (0.5%) were then added and the mixture
was incubated at 56°C for 1 h. Phage lysate was extracted
with an equal volume of phenol:chloroform:isoamyl alco-
hol (25:24:1). Chloroform extraction was repeated until
there was no phenol odor. An equal volume of isopropa-
nol (AR grade) was added and the sample was incubated
overnight at −20°C to precipitate the phage genomic
DNA. The pellet was washed with 75% ethanol, and then
deionized water was used to dissolve the precipitated gen-
omic DNA.Whole genome sequence and bioinformatics analysis
The genomic DNA of IME-AB2 was subjected to high-
throughput sequencing using a Life Technologies Ion
Personal Genome Machine Ion Torrent sequencer (San
Francisco, CA) according to the manufacturer’s instruc-
tions. The complete genome sequence of phage IME-AB2
was assembled using Velvet [47] and CLC Bio (Aarhus,
Denmark), and annotated using RAST [48] and InterPro
[49]. Sequence similarity analysis and comparison were
performed using NCBI packages.
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